Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hajdenberg

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Thrombosis and Haemostasis : JTH|December 23, 2004
Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttalJ Hajdenberg
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 1, 2016
Successful treatment of chronic recurrent life-threatening bleeding due to an acquired factor V Inhibitor with rituximab and steroidsM D Patel, J Hajdenberg
Annals of Internal Medicine|April 15, 2000
Factor VIII antibodies developing after a spider biteJ Hajdenberg, J Davis, R A Araujo
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Thrombosis and Haemostasis : JTH|December 23, 2004
Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttalJ Hajdenberg
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 1, 2016
Successful treatment of chronic recurrent life-threatening bleeding due to an acquired factor V Inhibitor with rituximab and steroidsM D Patel, J Hajdenberg
Annals of Internal Medicine|April 15, 2000
Factor VIII antibodies developing after a spider biteJ Hajdenberg, J Davis, R A Araujo
Pageof 1